These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23958017)

  • 1. Noninferiority trial comparing a first-generation cephalosporin with a third-generation cephalosporin in the treatment of nonsevere clinical mastitis in dairy cows.
    Schukken YH; Zurakowski MJ; Rauch BJ; Gross B; Tikofsky LL; Welcome FL
    J Dairy Sci; 2013 Oct; 96(10):6763-74. PubMed ID: 23958017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized noninferiority field trial evaluating cephapirin sodium for treatment of nonsevere clinical mastitis.
    Tomazi T; Lopes TAF; Masson V; Swinkels JM; Santos MV
    J Dairy Sci; 2018 Aug; 101(8):7334-7347. PubMed ID: 29778482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized clinical trial to evaluate the efficacy of a 5-day ceftiofur hydrochloride intramammary treatment on nonsevere gram-negative clinical mastitis.
    Schukken YH; Bennett GJ; Zurakowski MJ; Sharkey HL; Rauch BJ; Thomas MJ; Ceglowski B; Saltman RL; Belomestnykh N; Zadoks RN
    J Dairy Sci; 2011 Dec; 94(12):6203-15. PubMed ID: 22118109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized clinical trial comparing ceftiofur hydrochloride with a positive control protocol for intramammary treatment of nonsevere clinical mastitis in dairy cows.
    Cortinhas CS; Tomazi T; Zoni MSF; Moro E; Veiga Dos Santos M
    J Dairy Sci; 2016 Jul; 99(7):5619-5628. PubMed ID: 27157576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized noninferiority trial comparing 2 commercial intramammary antibiotics for the treatment of nonsevere clinical mastitis in dairy cows.
    Vasquez AK; Nydam DV; Capel MB; Ceglowski B; Rauch BJ; Thomas MJ; Tikofsky L; Watters RD; Zuidhof S; Zurakowski MJ
    J Dairy Sci; 2016 Oct; 99(10):8267-8281. PubMed ID: 27522408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The selective treatment of clinical mastitis based on on-farm culture results: I. Effects on antibiotic use, milk withholding time, and short-term clinical and bacteriological outcomes.
    Lago A; Godden SM; Bey R; Ruegg PL; Leslie K
    J Dairy Sci; 2011 Sep; 94(9):4441-56. PubMed ID: 21854917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized noninferiority clinical trial evaluating 3 commercial dry cow mastitis preparations: I. Quarter-level outcomes.
    Arruda AG; Godden S; Rapnicki P; Gorden P; Timms L; Aly SS; Lehenbauer TW; Champagne J
    J Dairy Sci; 2013 Jul; 96(7):4419-35. PubMed ID: 23628244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negatively controlled, randomized clinical trial to evaluate intramammary treatment of nonsevere, gram-negative clinical mastitis.
    Fuenzalida MJ; Ruegg PL
    J Dairy Sci; 2019 Jun; 102(6):5438-5457. PubMed ID: 30981475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatments of clinical mastitis occurring in cows on 51 large dairy herds in Wisconsin.
    Oliveira L; Ruegg PL
    J Dairy Sci; 2014 Sep; 97(9):5426-36. PubMed ID: 24997660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extended ceftiofur therapy for treatment of experimentally-induced Streptococcus uberis mastitis in lactating dairy cattle.
    Oliver SP; Almeida RA; Gillespie BE; Headrick SJ; Dowlen HH; Johnson DL; Lamar KC; Chester ST; Moseley WM
    J Dairy Sci; 2004 Oct; 87(10):3322-9. PubMed ID: 15377611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of extended ceftiofur intramammary therapy for treatment of subclinical mastitis in lactating dairy cows.
    Oliver SP; Gillespie BE; Headrick SJ; Moorehead H; Lunn P; Dowlen HH; Johnson DL; Lamar KC; Chester ST; Moseley WM
    J Dairy Sci; 2004 Aug; 87(8):2393-400. PubMed ID: 15328260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome comparison of immediate blanket treatment versus a delayed pathogen-based treatment protocol for clinical mastitis in a New York dairy herd.
    Vasquez AK; Nydam DV; Capel MB; Eicker S; Virkler PD
    J Dairy Sci; 2017 Apr; 100(4):2992-3003. PubMed ID: 28161180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective treatment of clinical mastitis based on on-farm culture results: II. Effects on lactation performance, including clinical mastitis recurrence, somatic cell count, milk production, and cow survival.
    Lago A; Godden SM; Bey R; Ruegg PL; Leslie K
    J Dairy Sci; 2011 Sep; 94(9):4457-67. PubMed ID: 21854918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negatively controlled, randomized clinical trial comparing different antimicrobial interventions for treatment of clinical mastitis caused by gram-positive pathogens.
    Tomazi T; Sumnicht M; Tomazi ACCH; Silva JCC; Bringhenti L; Duarte LM; Silva MMM; Rodrigues MX; Bicalho RC
    J Dairy Sci; 2021 Mar; 104(3):3364-3385. PubMed ID: 33358798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninferiority trial investigating the efficacy of a nonantibiotic intramammary therapy in the treatment of mild-to-moderate clinical mastitis in dairy cows with longer lasting udder diseases.
    Ziesch M; Wente N; Zhang Y; Zaremba W; Engl S; Krömker V
    J Vet Pharmacol Ther; 2018 Feb; 41(1):11-21. PubMed ID: 28449183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of antimicrobial susceptibility testing of bacterial pathogens isolated from the milk of dairy cows with clinical mastitis to predict response to treatment with cephapirin and oxytetracycline.
    Constable PD; Morin DE
    J Am Vet Med Assoc; 2002 Jul; 221(1):103-8. PubMed ID: 12420833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between in vitro susceptibility test results and treatment outcomes for gram-positive mastitis pathogens following treatment with cephapirin sodium.
    Apparao MD; Ruegg PL; Lago A; Godden S; Bey R; Leslie K
    J Dairy Sci; 2009 Jun; 92(6):2589-97. PubMed ID: 19447991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors associated with short-term post-treatment outcomes of clinical mastitis.
    Pinzón-Sánchez C; Ruegg PL
    J Dairy Sci; 2011 Jul; 94(7):3397-410. PubMed ID: 21700025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Normal milk microbiome is reestablished following experimental infection with Escherichia coli independent of intramammary antibiotic treatment with a third-generation cephalosporin in bovines.
    Ganda EK; Gaeta N; Sipka A; Pomeroy B; Oikonomou G; Schukken YH; Bicalho RC
    Microbiome; 2017 Jul; 5(1):74. PubMed ID: 28701174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial cure and somatic cell count response of dairy cows with a positive California Mastitis Test at calving to therapy with cephapirin sodium.
    Rosenberg JB; Love B; Patterson DL
    Vet Ther; 2002; 3(4):381-6. PubMed ID: 12584674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.